Please also visit GetIPT.com

Site outline:
Choosing IPT
Find a Doctor
IPT Training
About IPT
Other Diseases
Doctors Listing
Patient Stories
Patients Home
Articles & pubs
Site Index
About Us
Tell a Friend

This level:  





Chris Duffield Ph.D.
Stanford University, Department of Materials Science & Engineering
Bldg 550 Rm 551C, Stanford CA 94305-2205 CDIPTQ@IPTQ.com (650) 725-2643

Senator Dianne Feinstein
United States Senate
331 Hart Senate Office Building
Washington, D.C. 20510

Dear Senator Feinstein,

        First I congratulate you on your success in standing up to the drug companies to get costs lowered for HIV/AIDS treatment in sub-Saharan Africa.

        Second, I want to introduce you to a medical technology that could go even farther in lowering costs and increasing effectiveness of HIV/AIDS treatment, and for treatment of a wide variety of other diseases, in the US and worldwide. I am talking about insulin potentiation therapy (IPT).

        IPT is a simple, very safe, and apparently extremely effective medical technique that uses the hormone insulin to make standard drugs work much better, in smaller doses, and usually without any side effects. IPT is a "magic gun" that makes regular drugs into "magic bullets".

        Reported results include rapid successful treatment of breast, prostate, and lung cancer without surgery, radiation, or side effects. Also five years of relief from arthritic symptoms after just two or three IPT treatments. And rapid and effective treatment of HIV/AIDS and other infectious diseases. And amazing results in treatment of cardiovascular, respiratory, and neurological diseases, too.

        I think that IPT will eventually be recognized as one of the greatest medical discoveries of all time. On the same high level as antibiotics, anesthesia, and vaccination. I call it "The second discovery of insulin". When it is deployed in the US, the benefits of health care cost savings and improved outcomes for millions of patients will be worth trillions of dollars. Perhaps hundreds of trillions worldwide.

        You and your medical advisors can read all about IPT on a large website that I have created: www.IPTQ.org (I have been involved with IPT for 14 years.)

        The challenge of IPT is that, although it has an amazing track record during more than 120 doctor-years of experience over 70 years, in five countries, it is still essentially unknown. Clinical trials and laboratory research have never been done, even though IPT has been demonstrated continuously in or near the US since the 1930s. Because IPT does not fit into the usual medical mold, institutional barriers and skepticism have kept the benefits of IPT from humanity for 70 years. A few people at the NIH have known about IPT for years, but nothing has been done.

        Seventy years is much too long for us to have been denied access to IPT. Decisive action by the US government could get IPT quickly tested and rapidly deployed, especially for the AIDS epidemic in Africa, and for our cancer epidemic here at home. A broadly focused task force or initiative for IPT could overcome decades of institutional inertia and medical skepticism, and bring this about for AIDS and breast cancer by the end of this year. A continued initiative would bring even greater benefits for treatment of other diseases.

        My experience talking to doctors is that most of them are very skeptical of IPT, since it seems to them to be coming out of left field. But if it is the ball that we want, who cares where it is coming from? A little pressure from government leaders can help overcome this barrier, and ensure that this medical technique gets the attention it deserves.

        IPT is a small modification of standard medicine. Since it is not a new drug or device, it can be adopted immediately once its effectiveness is acknowledged and verified. Thus a minuscule low-risk investment in IPT research now, could quickly bring immense benefits for the US, the world, and for humanity, now and for all time to come. I calculate that the benefit-to-cost ratio is about a million to one, with low risk and short time frame. What more could we ask for? Long after all the other things that you and I have done, good or bad, are forgotten, we will be remembered and thanked for this one achievement.

        Please let me know how I may be of assistance to you in designing and launching such an Initiative.


Chris Duffield Ph.D.

Visiting Scholar
Department of Materials Science & Engineering
Stanford University



This level:  

Site index: 

Tell a friend about IPTQ.com
Entire IPTQ website Copyright 1999-2002 by Chris Duffield, Ph.D.  All rights reserved.
IPTQ, IPTQ.org, IPTQ.com, IPTQ.net, The second discovery of insulin, and IPTQ lifering and lifeboat logos are trademarks. 
Please read the IPTQ.com disclaimer.   
This page was last updated on  March 19, 2008.
Website technical corrections and suggestions -- email to IPTQ Webhost.
Please also visit GetIPT.com
website visitors since August 2002
Click on box for detailed statistics)

Chris Duffield, webhost